Paper2145367
The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.
Gooding LR and 4 others. J Immunol, 1990. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. Papers, record 2145367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2145367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoviruses, Human | Major topic |
| Cell Survival | Major topic |
| Oncogene Proteins, Viral | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Actin Cytoskeleton | |
| Adenovirus Early Proteins | |
| Animals | |
| Cell Line | |
| Cycloheximide | |
| Cytochalasins | |
| In Vitro Techniques | |
| Mice | |
| Molecular Weight |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA24710 | NCI NIH HHS | United States | R01CA024710 | PubMed and NIH | NIH RePORTER |
| CA40266 | NCI NIH HHS | United States | R01CA040266 | PubMed and NIH | NIH RePORTER |
| CA48219 | NCI NIH HHS | United States | R01CA048219 | PubMed and NIH | NIH RePORTER |
| R23CA024710 | NIH | NIH RePORTER |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42558152 | Adenoviral E3/49K: CD45-targeted immune evasion and therapeutic potential. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42558152 | PubMed |
| 36851572 | A Renaissance for Oncolytic Adenoviruses? | Viruses | 2023 | https://conductscience.org/library/papers/36851572 | PubMed |
| 34549981 | Biographical Feature: William S. M. Wold, Ph.D., 1944-2021. | J Virol | 2021 | https://conductscience.org/library/papers/34549981 | PubMed |
| 30046247 | Pathogenesis and management of adenoviral keratoconjunctivitis. | Infect Drug Resist | 2018 | https://conductscience.org/library/papers/30046247 | PubMed |
| 29875767 | Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma. | Front Immunol | 2018 | https://conductscience.org/library/papers/29875767 | PubMed |
| 28899926 | Peptides mediating DNA transport on microtubules and their impact on non-viral gene transfer efficiency. | Biosci Rep | 2017 | https://conductscience.org/library/papers/28899926 | PubMed |
| 28122980 | Suppression of Type I Interferon Signaling by E1A via RuvBL1/Pontin. | J Virol | 2017 | https://conductscience.org/library/papers/28122980 | PubMed |
| 24027303 | Homologous recombination in E3 genes of human adenovirus species D. | J Virol | 2013 | https://conductscience.org/library/papers/24027303 | PubMed |
| 22675546 | E3-14.7K is recruited to TNF-receptor 1 and blocks TNF cytolysis independent from interaction with optineurin. | PLoS One | 2012 | https://conductscience.org/library/papers/22675546 | PubMed |
| 21976655 | The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling. | J Virol | 2011 | https://conductscience.org/library/papers/21976655 | PubMed |
| 21142450 | Interference with intraepithelial TNF-α signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infection. | Viral Immunol | 2010 | https://conductscience.org/library/papers/21142450 | PubMed |
| 18461366 | Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival. | J Cancer Res Clin Oncol | 2008 | https://conductscience.org/library/papers/18461366 | PubMed |
| 17494079 | Investigation of adenovirus occurrence in pediatric tumor entities. | J Virol | 2007 | https://conductscience.org/library/papers/17494079 | PubMed |
| 17139321 | Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver. | Cancer Gene Ther | 2007 | https://conductscience.org/library/papers/17139321 | PubMed |
| 17024246 | Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. | J Clin Invest | 2006 | https://conductscience.org/library/papers/17024246 | PubMed |
| 16775326 | Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression. | J Virol | 2006 | https://conductscience.org/library/papers/16775326 | PubMed |
| 16227281 | Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex. | J Virol | 2005 | https://conductscience.org/library/papers/16227281 | PubMed |
| 15920462 | Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus. | Gene Ther | 2005 | https://conductscience.org/library/papers/15920462 | PubMed |
| 15542663 | Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. | J Virol | 2004 | https://conductscience.org/library/papers/15542663 | PubMed |
| 12502827 | The adenovirus e3 promoter is sensitive to activation signals in human T cells. | J Virol | 2003 | https://conductscience.org/library/papers/12502827 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2145367
GET https://conductscience.org/api/papers/v1/2145367/cited_by?page=2